After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. After-hours trades for Revance Therapeutics Inc. (RVNC) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.53, or 3.17%, to $17.23. The Revance Therapeutics Inc. has recorded 22,225 volume in the after hours trading session. The stock was recently discussed on Yahoo Finance as it revealed that Revance to Host Investor Day on September 19, 2023.
RVNC belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $16.70 and fluctuated between $16.98 as its day high and $16.29 as its day low. The current market capitalization of Revance Therapeutics Inc. is $1.51B. A total of 1.59 million shares were traded on the day, compared to an average of 1.43M shares.
Investors also take into account insider trades in predicting how the stock will perform in the future. During the recent three months, RVNC has seen 7 BUY and 7 SELL insider trades, representing the acquisition of 189,498 and the disposition of 132,031 shares. Over the last 12 months, there were 23 BUYs and 36 SELLs from insiders. Insiders purchased 533,584 shares during that period but sold 511,265.
In the most recent transaction, Moxie Dwight sold 11,000 shares of RVNC for 17.06 per share on Sep 06. After the transaction, the SVP, GC & Secretary now owns 44,066 company shares. In a previous transaction on Sep 05, Moxie Dwight sold 23,853 shares at 17.81 per share. RVNC shares that SVP, GC & Secretary owns now total 55,066.
Among the insiders who sold shares, Foley Mark J disposed of 26,279 shares on Aug 03 at a per-share price of $22.57. This resulted in the CEO holding 840,375 shares of RVNC after the transaction. In another insider transaction, Foley Mark J sold 26,279 shares at $24.94 per share on Jul 03. Company shares held by the CEO now total 866,654.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for RVNC in the last 3 months, the mean price target is $39.83 with high estimates of $65.00 and low estimates of $20.00. In terms of 52-week highs and lows, RVNC has a high of $37.98 and a low of $15.13.
As of this writing, RVNC has an earnings estimate of -$0.75 per share for the current quarter. EPS was calculated based on a consensus of 8 estimates, with a high estimate of -$0.52 per share and a lower estimate of -$1.05. The company reported an EPS of -$0.74 in the last quarter, which was -5.70% lower than expectations of -$0.7.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. RVNC’s latest balance sheet shows that the firm has $225.07M in Cash & Short Term Investments as of fiscal 2021. There were $324.51M in debt and $67.29M in liabilities at the time. Its Book Value Per Share was $0.32, while its Total Shareholder’s Equity was $68.47M.
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RVNC is Buy with a score of 4.50.